Lila Sciences pairs AI with autonomous laboratories to run scientific discovery across therapeutics, materials, energy, and aerospace.
Overview #
Lila Sciences #
Lila Sciences is an AI-for-science company applying what it calls scientific superintelligence to experimental discovery across therapeutics, materials, energy, chemicals, and aerospace. Lila Sciences pairs AI models with autonomous laboratory systems so that hypotheses are generated, tested on physical equipment, and refined against results in the same loop. It sells through two routes: Catalyst, an operating layer applied to a partner's existing research programs, and Creation, longer-horizon partnerships intended to originate new discoveries and turn them into products. Lila Sciences came out of Flagship Pioneering, the venture creation firm behind Moderna, which shapes how it builds companies around findings.
Production credibility: Lila Sciences has raised roughly $550M, including a $200M seed from Flagship Pioneering with General Catalyst, March Capital, and ARK Venture Fund, and it passed a $1.3B valuation in a later round that added NVIDIA as a backer, per Reuters. It was launched out of Flagship Pioneering, the firm that created Moderna. The company describes progress across several scientific domains rather than a single vertical; independent verification of specific discoveries remains limited, which is the standard caveat across this cohort of AI-science labs.
Key Features
- AI models coupled to autonomous laboratory hardware for hypothesis-to-experiment loops
- Catalyst — an operating layer applied to a partner's existing research program
- Creation — longer-horizon partnerships aimed at originating new discoveries
- Coverage spanning therapeutics, materials, energy, chemicals, and aerospace
- Learning from live experimental data rather than published literature alone
- Venture creation model inherited from Flagship Pioneering
Ideal Use Case
R&D organizations in life sciences, materials, and energy that want an AI-plus-automation layer attached to research programs already running, and corporate partners willing to enter multi-year discovery agreements rather than buy software. It is not a self-serve product, so the relevant reader is someone evaluating research partnerships or tracking which AI-science labs are converting funding into experimental output.
How Lila Sciences differentiates
Where Periodic Labs concentrates on the physical sciences and Isomorphic Labs on drug design, Lila Sciences spans several scientific domains at once and structures the work as partnerships rather than software licences. The Flagship Pioneering lineage matters commercially: that firm's model is to build companies around discoveries, so Lila is positioned to spin ventures out of results instead of only selling access to a platform. The breadth is also the open question, since multi-domain scope is harder to prove than a single measurable target.
FAQ
Q: What does Lila Sciences do? A: Lila Sciences combines AI with autonomous laboratories to run scientific discovery across therapeutics, materials, energy, chemicals, and aerospace, generating hypotheses and testing them on physical equipment.
Q: What are Catalyst and Creation? A: They are Lila's two engagement models. Catalyst applies its AI and automation layer to a partner's existing research program, while Creation is a longer-horizon partnership aimed at originating new discoveries and building products from them.
Q: Who backs Lila Sciences? A: It was launched out of Flagship Pioneering, the firm behind Moderna, and has raised roughly $550M in total, with investors including General Catalyst, March Capital, ARK Venture Fund, and NVIDIA.
Q: Is Lila Sciences available as software? A: No. It works through research partnerships rather than a self-serve product, so engagement starts with a conversation about a specific research program.
tl;dr
Lila Sciences applies AI and autonomous labs to scientific discovery across therapeutics, materials, energy, and aerospace, working through Catalyst and Creation partnerships. Launched by Flagship Pioneering, it has raised about $550M at a $1.3B+ valuation.